Skip to main content

Advertisement

Log in

Surgery for Gastric Cancer: State of the Art

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Surgery remains the undisputed mainstay in the management of gastric cancer, and advances in chemotherapy and radiation have improved outcomes in patients with resectable disease. A multidisciplinary approach, with active coordination across specialties dealing with management of gastric cancers provides improved quality of care and outcomes. Radical gastrectomy involves complete removal of tumor with adequate margins and appropriate lymph node dissection. Spleen preserving D2 lymphadenectomy is the present standard of care for all resectable tumors except few early tumors (T1a lesions) where endoscopic or local resections are deemed suitable. Perioperative or adjuvant chemotherapy should be offered to all patients with resectable tumor, having advanced T stage or node-positive disease. In patients with advanced tumors with invasion of adjacent organs, multivisceral resections can be offered selectively in the presence of good performance status and response to chemotherapy, which can lead to improvement in overall survival. The role of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy needs to be evaluated in patients with limited peritoneal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Image 1
Image 2
Image 3
Image 4

Similar content being viewed by others

References

  1. Dikshit RP, Mathur G, Mhatre S, Yeole BB (2011) Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol Off J Indian Soc Med Paediatr Oncol 32(1):3–11

    Article  Google Scholar 

  2. Sharma A, Radhakrishnan V (2011) Gastric cancer in India. Indian J Med Paediatr Oncol Off J Indian Soc Med Paediatr Oncol. 32(1):12–16

    Article  Google Scholar 

  3. GLOBOCAN Cancer fact sheets: stomach Cancers [Internet]. [cited 2017 Jan 19]. Available from: http://globocan.iarc.fr/old/FactSheets/cancers/stomach-new.asp

  4. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20

    Article  CAS  PubMed  Google Scholar 

  5. Noh SH, Park SR, Yang HK, Chung HC, Chung IJ, Kim SW, Kim HH, Choi JH, Kim HK, Yu W, Lee JI, Shin DB, Ji J, Chen JS, Lim Y, Ha S, Bang YJ, CLASSIC trial investigators (2014) Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol 15(12):1389–1396

    Article  CAS  PubMed  Google Scholar 

  6. Shrikhande SV, Sirohi B, Barreto SG, Chacko RT, Parikh PM, Pautu J et al (2014) Indian Council of Medical Research consensus document for the management of gastric cancer. Indian J Med Paediatr Oncol Off J Indian Soc Med Paediatr Oncol 35(4):239–243

    Article  Google Scholar 

  7. Shinohara T, Ohyama S, Yamaguchi T, Muto T, Kohno A, Kato Y et al (2005) Clinical value of multidetector row computed tomography in detecting lymph node metastasis of early gastric cancer. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 31(7):743–748

    CAS  Google Scholar 

  8. Puli SR, Reddy JBK, Bechtold ML, Antillon MR, Ibdah JA (2008) How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review. World J Gastroenterol: WJG 14(25):4011–4019

    Article  PubMed  PubMed Central  Google Scholar 

  9. D’Ugo DM, Pende V, Persiani R, Rausei S, Picciocchi A (2003) Laparoscopic staging of gastric cancer: an overview. J Am Coll Surg 196(6):965–974

    Article  PubMed  Google Scholar 

  10. Cardona K, Zhou Q, Gönen M, Shah MA, Strong VE, Brennan MF, Coit DG (2013) Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Ann Surg Oncol 20(2):548–554

    Article  PubMed  Google Scholar 

  11. Irino T, Sano T, Hiki N, Ohashi M, Nunobe S, Kumagai K, Ida S, Yamaguchi T (2017) Diagnostic staging laparoscopy in gastric cancer: a prospective cohort at a cancer institute in Japan. Surg Endosc 29

  12. Huang J, Luo H, Zhou C, Zhan J, Rao X, Zhao G, Zhu Z (2017) Yield of staging laparoscopy for incurable factors in Chinese patients with advanced gastric cancer. J Laparoendosc Adv Surg Tech A 26

  13. Machairas N, Charalampoudis P, Molmenti EP, Kykalos S, Tsaparas P, Stamopoulos P, Sotiropoulos GC (2017) The value of staging laparoscopy in gastric cancer. Ann Gastroenterol 30(3):287–294

    PubMed  PubMed Central  Google Scholar 

  14. Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H et al (2003) The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 6(3):142–145

    Google Scholar 

  15. Bagaria B, Sood S, Sharma R, Lalwani S (2013) Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis). Cancer Biol Med 10(3):148–157

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Namasivayam S, Martin DR, Saini S (2007) Imaging of liver metastases: MRI. Cancer Imaging 7(1):2–9

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hopkins S, Yang GY (2011) FDG PET imaging in the staging and management of gastric cancer. J Gastrointest Oncol 2(1):39–44

    PubMed  PubMed Central  Google Scholar 

  18. Washington K (2010) 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol 17(12):3077–3079

    Article  PubMed  Google Scholar 

  19. Uedo N, Iishi H, Tatsuta M, Ishihara R, Higashino K, Takeuchi Y et al (2006) Longterm outcomes after endoscopic mucosal resection for early gastric cancer. Gastric Cancer Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc 9(2):88–92

    Google Scholar 

  20. Morita S, Katai H, Saka M, Fukagawa T, Sano T, Sasako M (2008) Outcome of pylorus-preserving gastrectomy for early gastric cancer. Br J Surg 95(9):1131–1135

    Article  CAS  PubMed  Google Scholar 

  21. Mochiki E, Kamiyama Y, Aihara R, Nakabayashi T, Asao T, Kuwano H (2005) Laparoscopic assisted distal gastrectomy for early gastric cancer: five years’ experience. Surgery. 137(3):317–322

    Article  PubMed  Google Scholar 

  22. Hiki N, Nunobe S, Kubota T, Jiang X (2013) Function-preserving gastrectomy for early gastric cancer. Ann Surg Oncol 20(8):2683–2692

    Article  PubMed  Google Scholar 

  23. Kwon YH, Heo J, Lee HS, Cho CM, Jeon SW (2014) Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients. Aliment Pharmacol Ther 39(6):609–618

    Article  CAS  PubMed  Google Scholar 

  24. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345(10):725–730

    Article  CAS  PubMed  Google Scholar 

  25. Lee J, Lim DH, Kim S, Park SH, Park JO, Park YS, Lim HY, Choi MG, Sohn TS, Noh JH, Bae JM, Ahn YC, Sohn I, Jung SH, Park CK, Kim KM, Kang WK (2012) Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol Off J Am Soc Clin Oncol 30(3):268–273

    Article  CAS  Google Scholar 

  26. Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, Cascinu S, Barni S, Labianca R, Torri V (2000) Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell’Apparato Digerente). Ann Oncol 11(7):837–835

    Article  CAS  PubMed  Google Scholar 

  27. Bang Y-J, Kim Y-W, Yang H-K, Chung HC, Park Y-K, Lee KH et al (2012) Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 379(9813):315–321

    Article  CAS  PubMed  Google Scholar 

  28. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K, ACTS-GC Group (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357(18):1810–1820

    Article  CAS  PubMed  Google Scholar 

  29. GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International Collaboration) Group, Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y et al (2010) Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 303(17):1729–1737

    Article  Google Scholar 

  30. Murakami T (1971) Pathomorphological diagnosis. Definition and gross classification of early gastric cancer. Gann Monogr Cancer Res 11:53–55

    Google Scholar 

  31. Kitaoka H, Yoshikawa K, Suzuki M, Yoshida S, Yamagushi H, Hirota T et al (1983) Study on local resection of the tumor with preservation of the regional lymph-nodes for early gastric cancer (in Japanese). Nihon Gan Chiryo Gakkai Shi 18:969–978

    CAS  PubMed  Google Scholar 

  32. Ohgami M, Otani Y, Kumai K, Kubota T, Kim YI, Kitajima M (1999) Curative laparoscopic surgery for early gastric cancer: five years experience. World J Surg 23:187–192

    Article  CAS  PubMed  Google Scholar 

  33. Sano T, Kobori O, Muto T (1992) Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg 79:241–244

    Article  CAS  PubMed  Google Scholar 

  34. Kitagawa Y, Takeuchi H, Takagi Y, Natsugoe S, Terashima M, Murakami N, Fujimura T, Tsujimoto H, Hayashi H, Yoshimizu N, Takagane A, Mohri Y, Nabeshima K, Uenosono Y, Kinami S, Sakamoto J, Morita S, Aikou T, Miwa K, Kitajima M (2013) Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol 31(29):3704–3710

    Article  PubMed  Google Scholar 

  35. Kim YW, Baik YH, Yun YH, Nam BH, Kim DH, Choi IJ, Bae JM (2008) Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 248(5):721–727

    Article  PubMed  Google Scholar 

  36. Kim W, Kim HH, Han SU, Kim MC, Hyung WJ, Ryu SW, Cho GS, Kim CY, Yang HK, Park DJ, Song KY, Lee SI, Ryu SY, Lee JH, Lee HJ, Korean Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) Group (2016) Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg 263(1):28–35

    Article  PubMed  Google Scholar 

  37. Lu W, Gao J, Yang J, Zhang Y, Lv W, Mu J, Dong P, Liu Y (2016) Long-term clinical outcomes of laparoscopy-assisted distal gastrectomy versus open distal gastrectomy for early gastric cancer: a comprehensive systematic review and meta-analysis of randomized control trials. Medicine (Baltimore) 95(27):e3986

    Article  Google Scholar 

  38. Deng Y, Zhang Y, Guo TK (2015) Laparoscopy-assisted versus open distal gastrectomy for early gastric cancer: a meta-analysis based on seven randomized controlled trials. Surg Oncol 24(2):71–77

    Article  CAS  PubMed  Google Scholar 

  39. Bozzetti F, Marubini E, Bonfanti G et al (1999) Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 230:170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Gouzi JL, Huguier M, Fagniez PL et al (1989) Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 209:162

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Japanese Gastric Cancer Association (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14:113–123

    Article  Google Scholar 

  42. Sugoor P, Shah S, Dusane R, Desouza A, Goel M, Shrikhande SV (2016) Proximal gastrectomy versus total gastrectomy for proximal third gastric cancer: total gastrectomy is not always necessary. Langenbeck's Arch Surg 401(5):687–697

    Article  Google Scholar 

  43. Buhl K, Schlag P, Herfarth C (1990) Quality of life and functional results following different types of resection for gastric carcinoma. Eur J Surg Oncol 16:404

    CAS  PubMed  Google Scholar 

  44. Pu YW, Gong W, Wu YY et al (2013) Proximal gastrectomy versus total gastrectomy for proximal gastric carcinoma. A meta-analysis on postoperative complications, 5-year survival, and recurrence rate. Saudi Med J 34:1223

    PubMed  Google Scholar 

  45. Shen W-S, Xi H-Q, Wei B, Chen L (2014) Effect of gastrectomy with bursectomy on prognosis of gastric cancer: a meta-analysis. World J Gastroenterol 20(40):14986–14991

    Article  PubMed  PubMed Central  Google Scholar 

  46. Terashima M, Doki Y, Kurokawa Y, Mizusawa J, Katai H, Yoshikawa T, Kimura Y, Takiguchi S, Nishida Y, Iwasaki Y, Fukushima N, Kaji M, Hirao M, Kurita A, Ito S, Yabusaki H, Sano T, Katayama H, Nakamura K, Sasako M, Stomach Cancer Study Group, Japan Clinical Oncology Group (2017) Primary results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001). J Clin Oncol 35(4_suppl):5

    Article  Google Scholar 

  47. Japanese Gastric Cancer Association (2010) Japanese classification of gastric cancer, 14th edn. Kanehara & Co. Ltd, Tokyo

    Google Scholar 

  48. Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, Kakade AC, Hawaldar R (2006) D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg 23(3):192–197

    Article  PubMed  Google Scholar 

  49. Bonenkamp J, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW (1995) Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345(8952):745–748

    Article  CAS  PubMed  Google Scholar 

  50. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 347(9007):995–999

    Article  CAS  PubMed  Google Scholar 

  51. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AF, Lui WY, Whang-Peng J (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7:309–315

    Article  CAS  PubMed  Google Scholar 

  52. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ (2010) Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 11:439–449

    Article  PubMed  Google Scholar 

  53. Jiang L, Yang KH, Guan QL, Zhao P, Chen Y, Tian JH (2013) Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis. J Surg Oncol 107(8):807–814

    Article  PubMed  Google Scholar 

  54. Biondi A, D'Ugo D, Cananzi FC, Papa V, Borasi A, Sicoli F, Degiuli M, Doglietto G, Persiani R (2015) Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? Eur J Surg Oncol 41(6):779–786

    Article  CAS  PubMed  Google Scholar 

  55. Bozzetti F, Bonfanti G, Bufalino R et al (1982) Adequacy of margins of resection in gastrectomy for cancer. Ann Surg 196:685–690

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. National Comprehensive Cancer Network. Gastric cancer (Version 1.2017). http://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf

  57. Mine S, Sano T, Hiki N, Yamada K, Kosuga T, Nunobe S, Yamaguchi T (2013) Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction. Br J Surg 100:1050–1054

    Article  CAS  PubMed  Google Scholar 

  58. Postlewait LM, Squires MH 3rd, Kooby DA et al (2015) The importance of the proximal resection margin distance for proximal gastric adenocarcinoma: a multi-institutional study of the US Gastric Cancer Collaborative. J Surg Oncol 112:203–207

    Article  PubMed  Google Scholar 

  59. Lee CM, Jee YS, Lee JH et al (2014) Length of negative resection margin does not affect local recurrence and survival in the patients with gastric cancer. World J Gastroenterol 20:10518–10524

    Article  PubMed  PubMed Central  Google Scholar 

  60. Braga M, Molinari M, Zuliani W, Foppa L, Gianotti L, Radaelli G, Cristallo M, di Carlo V (1996) Surgical treatment of gastric adenocarcinoma: impact on survival and quality of life. A prospective ten year study. Hepato-Gastroenterology 43:187–193

    CAS  PubMed  Google Scholar 

  61. Rausei S, Mangano A, Galli F et al (2013) Quality of life after gastrectomy for cancer evaluated via the EORTC QLQ-C30 and QLQ-STO22 questionnaires: surgical considerations from the analysis of 103 patients. Int J Surg 11:S104–S109

    Article  PubMed  Google Scholar 

  62. Squires MH III, Kooby DA, Poultsides GA et al (2014) Is it time to abandon the 5-cm margin rule during resection of distal gastric adenocarcinoma? A multi-institution study of the U.S. Gastric Cancer Collaborative. Ann Surg Oncol 22:1243–1251

    Article  PubMed  Google Scholar 

  63. Kakeji Y, Tsujitani S, Baba H, Moriguchi S, Mori M, Maehara Y, Kamegawa T, Sugimachi K (1991) Clinicopathologic features and prognostic significance of duodenal invasion in patients with distal gastric carcinoma. Cancer 68:380–384

    Article  CAS  PubMed  Google Scholar 

  64. Bickenbach KA, Gonen M, Strong V, Brennan MF, Coit DG (2013) Association of positive transection margins with gastric cancer survival and local recurrence. Ann Surg Oncol 20:2663–2668

    Article  CAS  PubMed  Google Scholar 

  65. Shen JG, Cheong JH, Hyung WJ, Kim J, Choi SH, Noh SH (2006) Intraoperative frozen section margin evaluation in gastric cancer of the cardia surgery. Hepato-Gastroenterology 53:976–978

    PubMed  Google Scholar 

  66. Spicer J, Benay C, Lee L, Rousseau M, Andalib A, Kushner Y, Marcus V, Ferri L (2014) Diagnostic accuracy and utility of intraoperative microscopic margin analysis of gastric and esophageal adenocarcinoma. Ann Surg Oncol 21:2580–2586

    Article  PubMed  Google Scholar 

  67. Kim SH, Karpeh MS, Klimstra DS, Leung D, Brennan MF (1999) Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg 3:24–33

    Article  CAS  PubMed  Google Scholar 

  68. Chen JD, Yang XP, Shen JG, Hu WX, Yuan XM, Wang LB (2013) Prognostic improvement of reexcision for positive resection margins in patients with advanced gastric cancer. Eur J Surg Oncol 39:229–234

    Article  PubMed  Google Scholar 

  69. Cho BC, Jeung HC, Choi HJ, Rha SY, Hyung WJ, Cheong JH, Noh SH, Chung HC (2007) Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute. J Surg Oncol 95:461–468

    Article  PubMed  Google Scholar 

  70. Nagata T, Ichikawa D, Komatsu S, Inoue K, Shiozaki A, Fujiwara H, Okamoto K, Sakakura C, Otsuji E (2011) Prognostic impact of microscopic positive margin in gastric cancer patients. J Surg Oncol 104:592–597

    Article  PubMed  Google Scholar 

  71. Roberts P, Seevaratnam R, Cardoso R, Law C, Helyer L, Coburn N (2012) Systematic review of pancreaticoduodenectomy for locally advanced gastric cancer. Gastric Cancer 15(Suppl 1):S108–S115

    Article  PubMed  Google Scholar 

  72. Brar SS, Seevaratnam R, Cardoso R, Yohanathan L, Law C, Helyer L, Coburn NG (2012) Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer 15(Suppl 1):S100–S107 Epub 2011 Jul 23

    Article  PubMed  Google Scholar 

  73. Sun J, Song Y, Wang Z, Gao P, Chen X, Xu Y et al (2012) Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer 12:526

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Glehen O, Passot G, Villeneuve L, Vaudoyer D, Bin-Dorel S, Boschetti G et al (2014) GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer 14:183

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Garofalo A, Valle M, Garcia J, Sugarbaker PH (2006) Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol 32:682–685

    Article  CAS  PubMed  Google Scholar 

  76. Roviello F, Caruso S, Neri A, Marrelli D (2013) Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 39(12):1309–1316

    CAS  Google Scholar 

  77. Facchiano E, Scaringi S, Kianmanesh R, Sabate JM, Castel B, Flamant Y, Coffin B, Msika S (2008) Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer. Eur J Surg Oncol 34:154–158

    Article  CAS  PubMed  Google Scholar 

  78. Kim Y-I, Choi IJ (2015) Endoscopic management of tumor bleeding from inoperable gastric cancer. Clin Endosc 48(2):121–127

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Lee HJ, Shin JH, Yoon HK, Ko GY, Gwon DI, Song HY, Sung KB (2009) Transcatheter arterial embolization in gastric cancer patients with acute bleeding. Eur Radiol 19(4):960–965

    Article  PubMed  Google Scholar 

  80. Kasakura Y, Ajani JA, Fujii M, Mochizuki F, Takayama T (2002) Management of perforated gastric carcinoma: a report of 16 cases and review of world literature. Am Surg 68(5):434–440

    PubMed  Google Scholar 

  81. Lee JA, Lim DH, Park W, Ahn YC, Huh SJ (2009) Radiation therapy for gastric cancer bleeding. Tumori. 95(6):726–730

    Article  CAS  PubMed  Google Scholar 

  82. No JH, Kim SW, Lim CH, Kim JS, Cho YK, Park JM, Lee IS, Choi MG, Choi KY (2013) Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with good performance status: endoscopic stenting versus surgery. Gastrointest Endosc 78(1):55–62

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shailesh V. Shrikhande.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhandare, M.S., Chaudhari, V. & Shrikhande, S.V. Surgery for Gastric Cancer: State of the Art. Indian J Surg 83 (Suppl 3), 719–729 (2021). https://doi.org/10.1007/s12262-019-02061-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-019-02061-5

Keywords

Navigation